Research Portfolio

We invite you to learn about the Foundation's research grants. The search feature and the table below represent the Foundation's complete research portfolio. You may search the complete list of grants by status (open/active or closed/inactive), health category, and disease.

If you are interested in a specific research program area, browse the recently funded research by program area.

To browse active grants you may also wish to view the 2017 Grants Portfolio publication.

Grant Status:
Needs Funding?
Health Category:
Disease:
 

Search Results

Click on the grant title to view the project details.  Sort your results by clicking on the column header.  You can use the above search criteria to narrow your results.

GrantNum Title Institution Investigator Status Health Category
00990-A 00990-A: Prognostic Indicators for Anal Sac Gland Carcinoma in the English Cocker Spaniel and Preparing to Map Predisposition to this Tumor University of Cambridge Sargan, David Closed Oncology
982 982: Evaluation of Efficacy of Fasaret in Dogs with Osteosarcoma ApopLogic Pharmaceuticals, LLC Bellgrau, Don Closed Oncology
2025 2025: Growth Signaling Pathways in the Pathogenesis and Treatment of Canine Cancer University of Wisconsin, Madison Helfand, Stuart Closed Oncology
00978-A 00978-A: Isolation of the Canine Telomerase Reverse Transcriptase (TERT) Subunit and Generation of Dominant-Negative Mutants for Telomerase Inhibition University of Pennsylvania Long, Sam Closed Oncology
976 976: Investigating the Role of STAT3 Activation in Canine Osteosarcoma Ohio State University London, Cheryl Closed Oncology
00947B 00947B: Heritable and Sporadic Genetic Lesions in Canine Osteosarcoma University of Minnesota Modiano, Jaime Closed Oncology
00947A 00947A: Heritable and Sporadic Genetic Lesions in Canine Osteosarcoma North Carolina State University Breen, Matthew Closed Oncology
2010 2010: Dissecting the Biology and Genetics of c-Kit Mutations in Canine Mast Cell Tumors University of California, Davis London, Cheryl Closed Oncology
00935B 00935B: Positional Cloning of Two Genes for Malignant Histiocytosis (MH) in the Bernese Mountain Dog CNRS - University of Rennes Andre, Catherine Closed Oncology
00935A 00935A: Positional Cloning of Two Genes for Malignant Histiocytosis (MH) in the Bernese Mountain Dog National Human Genome Research Institute Ostrander, Elaine Closed Oncology
00910-A 00910-A: Epidermal Growth Factor Receptor and Cyclooxygenase-2 Cross-Talk in Canine Mammary Cancers Texas A&M University Banu, Sakhila Closed Oncology
00896-A 00896-A: Phase I Clinical Trial and Pharmacokinetics of Intravesical Mytomycin C (MMC) for the Treatment of Canine Transitional Cell Carcinoma (TC) of the Urinary Bladder Purdue University Knapp, Deborah Closed Oncology
00888-A 00888-A: Generation of Canine Single Chain Fragment Variable Antibody Libraries for the Identification and Targeting of Tumor-Associated Antigens in the Dog University of Pennsylvania Mason, Nicola Closed Oncology
00878-A 00878-A: MicroRNA Expression in the Domestic Dog and Its Role in Canine Cancer Texas A&M University Tsai, Kate Closed Oncology
00848-A 00848-A: Evaluation of Neutrophil Function in Treated Tumor-Bearing Dogs University of Tennessee LeBlanc, Casey Closed Oncology
00841-A 00841-A: Pharmacokinetics and Phase I Clinical Trial of High-Dose Intermittent Oral Artemisinin in Dogs with Spontaneous Tumors Ohio State University Couto, Guillermo Closed Oncology
00837-A 00837-A: Prognostic Significance of Ezrin Expression in Canine High-Grade Soft Tissue Sarcoma Colorado State University Vickery, Kathryn Closed Oncology
00830-A 00830-A: A Pilot Study to Determine the Molecular Characterization of Canine Follicular Thyroid Carcinoma Iowa State University Wilke, Vicki Closed Oncology
00826-A 00826-A: Percutaneous Cryoablation in Canine Osteosarcoma University of Wisconsin, Madison Bjorling, Dale Closed Oncology
00825-A 00825-A: Microarray Analysis of Immune Responses Elicited by CERT + hGMCSF in Dogs With Advanced Cancer Sirius Medicine, LLC Morris, Kevin Closed Oncology
822 822: Canine Comparative Oncology and Genomics Consortium (CCOGC) Canine Comparative Oncology and Genomics Consortium Inc Breen, Matthew Closed Oncology
00811-A 00811-A: Gene Expression Profiling of Canine Lymphocytic Leukemia Colorado State University Avery, Anne Closed Oncology
00809-A 00809-A: Rel Transformation of Canine Lymphoid Cells: Towards the Development of Relevant Canine Lymphoma Cell Lines North Carolina State University Suter, Steven Closed Oncology
790 790: MicroRNA Profiling and MicroRNA-Based Treatment of Canine Cancers Ohio State University Kisseberth, William Closed Oncology
778 778: Role of Regulatory T Cells in Dogs with Osteosarcoma Colorado State University Biller, Barbara Closed Oncology
768 768: A Collaborative Study by Veterinary Oncologists, Pathologists and Diagnostic Laboratories to Enhance the Detection, Diagnosis and Treatment of Canine Lymphoma University of Illinois Valli, Ted Closed Oncology
760 760: Cellular Genomics - Molecular Cytogenetic Investigation of Canine Soft Tissue Sarcomas North Carolina State University Breen, Matthew Closed Oncology
00757B 00757B: Hereditary Mutations in Genes Associated with Osteosarcoma in Large Dog Breeds University of Michigan Comstock, Kenine Closed Oncology
00757A 00757A: Hereditary Mutations in Genes Associated with Osteosarcoma in Large Dog Breeds Broad Institute Lindblad-Toh, Kerstin Closed Oncology
00754B 00754B: Mapping of the Gene for Transitional Cell Carcinoma in the Scottish Terrier and West Highland White Terrier National Human Genome Research Institute Ostrander, Elaine Closed Oncology
00754A 00754A: Mapping of the Gene for Transitional Cell Carcinoma in the Scottish Terrier & West Highland White Terrier Purdue University Knapp, Deborah Closed Oncology
00718-A 00718-A: Ras Mutations in Canine Lymphoid and Myeloid Leukemias University of Liverpool Blackwood, Laura Closed Oncology
00022101T 00022101T: Development of Anti-Canine Il-2R? Antibodies Using CpG Oligodeoxynucleotide Vaccination Oregon State University Helfand, Stuart Closed Oncology
0002646T 0002646T: Characterization of Receptor Tyrosine Kinase Dysfunction in Malignant Histiocytosis Ohio State University London, Cheryl Closed Oncology
0002465T 0002465T: Identification and Characterization of Genetic Mutations in Canine Mast Cell Tumors Ohio State University London, Cheryl Closed Oncology
00615B 00615B: Heritable and Sporadic Genetic Lesions in Canine Lymphoma North Carolina State University Breen, Matthew Closed Oncology
1817 1817: Genetics of Malignant Histiocytomas in the Flat-Coated Retriever University of Texas King, Terri Closed Oncology
678 678: Generation and Analysis of Canine Bone Marrow Derived Mast Cells Ohio State University London, Cheryl Closed Oncology
00675-A 00675-A: Evaluation of the Safety of Cisplatin/COX-2 Inhibitor Treatment for Canine Cancer Purdue University Knapp, Deborah Closed Oncology
00593B 00593B: Mapping Genes Associated with Canine Hemangiosarcoma Tufts University Azuma, Chieko Closed Oncology
00664-A 00664-A: Exploration of Alternative Samples for Prognostic Assay of Canine Cancers: Getting the Most Out of Existing Samples and Testing New Ones Collected Without Surgery Animal Health Trust Starkey, Mike Closed Oncology
632 632: MicroRNAs and Canine Lymphoma Ohio State University Kisseberth, William Closed Oncology
00615A 00615A: Heritable and Sporadic Genetic Lesions in Canine Lymphoma University of Colorado Modiano, Jaime Closed Oncology
613 613: The Prognostic Significance of Chromosome Aneuploidy in Canine Lymphoma North Carolina State University Breen, Matthew Closed Oncology
595 595: The Development of a Cellular Delivery System for RNA Interference Targeted to Canine Tumors University of Edinburgh Argyle, David Closed Oncology
00593A 00593A: Mapping Genes Associated with Canine Hemangiosarcoma Broad Institute Lindblad-Toh, Kerstin Closed Oncology
591 591: In Vitro Effects of the Milk Thistle Extract Silibinin in Canine Tumor Cells Colorado State University Thamm, Douglas Closed Oncology
422 422: Tailored Antitumor Vaccines for Canine Hemangiosarcoma University of Colorado Cancer Center Bellgrau, Don Closed Oncology
415 415: Anti-HLA-DR Antibody Therapy in Canine B-cell Lymphoma: Preliminary Clinical Evaluation Cornell University Page, Rodney Closed Oncology
0001626T 0001626T: Significance of Tumor Suppressor Genes in Canine Cancer University of Colorado Modiano, Jaime Closed Oncology
1626 1626: Significance of Tumor Suppressor Genes in Canine Cancer Texas A&M University Modiano, Jaime Closed Oncology
00373B 00373B: Mapping Genes Associated with Osteosarcoma in Large Dog Breeds University of Michigan Comstock, Kenine Closed Oncology
00373A 00373A: Mapping Genes Associated with Osteosarcoma in Large Dog Breeds Broad Institute Lindblad-Toh, Kerstin Closed Oncology
366 366: Molecular Control of COX-2 Expression and Regulation of Prostaglandin Transport in Canine Mammary Tumors University of Montreal Dore, Monique Closed Oncology
349 349: Genetic Epidemiology of Cancer in the Golden Retriever The Wistar Institute Jeglum, K. Closed Oncology
00339-A 00339-A: Expression of Vascular Endothelial Growth Factor (VEGF) and Basic Fibroblast Growth Factor (bFGF) in Canine Oral Malignant Melanoma Auburn University Taylor, Kathryn Closed Oncology
00336B 00336B: Mapping of the Gene for Malignant Histiocytosis in the Bernese Mountain Dog CNRS - University of Rennes Galibert, Francis Closed Oncology
00336A 00336A: Mapping of the Gene for Malignant Histiocytosis in the Bernese Mountain Dog National Human Genome Research Institute Ostrander, Elaine Closed Oncology
1456 1456: Immunohistochemical and Mutational Analysis of p53 in Archival Benign and Malignant Tumors of Flat-Coated Retrievers Ohio State University Couto, Guillermo Closed Oncology
272 272: Oligonucleotide Microarray Gene Expression Profiling of Canine Lymphoma Ohio State University Kisseberth, William Closed Oncology
267 267: Investigation into Combined Molecular Approaches to Treat Hemangiosarcoma University of Wisconsin, Madison Argyle, David Closed Oncology
257 257: Investigation of Predictors of Outcome for Canine Mast Cell Tumors Auburn University Whitley, Elizabeth Closed Oncology
249 249: Genomics of Canine Brain Neoplasia North Carolina State University Breen, Matthew Closed Oncology
237 237: Molecular Epidemiology of Ehrlichia and Bartonella spp. Infection in Golden Retrievers with Lymphoma North Carolina State University Breitschwerdt, Edward Closed Oncology
02321 02321: Clinical Trial of Procaspase-3 Activator (PAC-1) in Combination with Hydroxyurea for Treatment of Canine Meningioma University of Illinois Fan Open Oncology
02317 02317: The Role of Complex Translocations Associated with TP53 Somatic Mutations for Aiding Prognosis of Canine Diffuse Large B cell Lymphoma North Carolina State University Breen Open Oncology
02316 02316: Genetic Risk Factors for Canine T zone Lymphoma Colorado State University Avery Open Oncology
02315-A 02315-A: Discovering Peptide Targets for Development of Adoptive Cell Therapy for Peripheral T-Cell Lymphoma North Carolina State University Hess Open Oncology
02309 02309: Targeting the Cancer Epigenome: The Effect of Specific Histone Lysine Methyltransferase Inhibition in Canine B-Cell Lymphoma Cornell University McCleary-Wheeler Open Oncology
02304-A 02304-A: Investigating a Biomarker and Novel Therapeutic Target for Canine Diffuse Large B Cell Lymphoma North Carolina State University Luff Open Oncology
02234-MOU 02234-MOU: A Novel Approach for Prevention of Canine Hemangiosarcoma University of Minnesota Modiano Open Oncology
02217 02217: A Novel Mechanism to Regulate the Growth of Canine Hemangiosarcoma University of Minnesota Dickerson Open Oncology
02215 02215: A Cancer Vaccine for Canine Osteosarcoma University of Florida Milner Open Oncology
02204 02204: Using Enhanced Imaging to Evaluate Tumor Margins for Canine Mammary Cancer and Soft Tissue Sarcoma University of Illinois Selmic Open Oncology
02171-MOU 02171-MOU: Histiocytic Sarcoma in Bernese Mountain Dogs: Novel Approaches To Treatment Michigan State University Yuzbasiyan-Gurkan Open Oncology
02093-A 02093-A: Sequencing Histiocytic Sarcoma (HS) loci identified by Genetic Association studies in the Bernese Mountain Dog (BMD) CNRS - University of Rennes Andre Open Oncology
02092-A 02092-A: Developing the Use of a Novel Imaging Technique to Define a Dog's Potential Responsiveness to Chemotherapy Purdue University Childress, Michael Open Oncology
02091-A 02091-A: Differentiating between Localized and Disseminated Histiocytic Sarcoma in Bernese Mountain Dogs National Human Genome Research Institute Ostrander Closed Oncology
02081-A 02081-A: Integrating Cutting Edge Science with Scientific Training to Defeat Hemangiosarcoma University of Minnesota Modiano, Jaime Open Oncology
2071 2071: Development of a Therapeutic Brain Tumor Vaccine University of Minnesota Pluhar, Grace Open Oncology
00205-A 00205-A: Relationship of Clinical Stage and Ki-67 Expression to Recurrence Following Radiotherapy of Canine Intranasal Neoplasia University of Wisconsin, Madison Adams, WM Closed Oncology
01949-A 01949-A: Targeting the Cell's Activation Machinery to Halt Tumor Metastasis in Canine Osteosarcoma Oregon State University Bracha, Shay Closed Oncology
2667 2667: Cellular Genomics - Molecular Cytogenetic Investigation of Canine Soft Tissue Sarcomas North Carolina State University Breen, Matthew Closed Oncology
01929-A 01929-A: Arginine Dependence: Identification of Cancer's Achilles Heel University of California, Davis Rodriguez Jr, Carlos Closed Oncology
01925-A 01925-A: Discovery of Novel Micro-Ribonucleic Acids for Diagnosis and Prognosis of Canine Hemangiosarcoma Auburn University Smith, Bruce Closed Oncology
01918-G 01918-G: Discovery of Biomarkers to Detect Lymphoma Risk, Classify For Treatment, and Predict Outcome in Golden Retrievers University of Missouri, Columbia Bryan, Jeffery Open Oncology
01914-A 01914-A: Defining the Genes That Contribute to the Development of Soft Tissue Sarcomas University of Utrecht Boerkamp, Kim Open Oncology
01912-A 01912-A: Enhancing the Safety and Efficacy of Anti-Cancer Drugs in Dogs Research Foundation of State University of New York Blanco, Javier Open Oncology
01911-A 01911-A: Enhanced Hemangiosarcoma Therapy Using a Novel Combination of Drugs That Target Tumor Proliferation Van Andel Research Institute Duesbery, Nicholas Open Oncology
2646 2646: Characterization of Receptor Tyrosine Kinase Dysfunction in Malignant Histiocytosis University of California, Davis London, Cheryl Closed Oncology
01903-A 01903-A: Defining the Anti-Tumor Activity of Monocytes in Osteosarcoma North Carolina State University Lascelles, Duncan Open Oncology
01889-G 01889-G: Innovations in Prevention, Diagnosis, and Treatment of Cancer - Goldens Lead the Way University of Minnesota Modiano, Jaime Open Oncology
01876-A 01876-A: Ensuring That Emerging Stem Cell Treatments Do Not Activate or Exacerbate Cancer in Dogs Colorado State University Thamm, Douglas Open Oncology
01872-A 01872-A: Using Ultrasound as a Cost Effective and Non-Invasive Technique for Early Diagnosis of Solid Tumors Louisiana State University Rademacher, Nathalie Closed Oncology
2629 2629: Clinical and Immunological Outcomes in Dogs with Osteosarcoma Treated with Intratumoral Interleukin-12 Microspheres University of Wisconsin, Madison Helfand, Stuart Closed Oncology
1843 1843: Further Investigation of the Genes Controlling Canine Leukemia to Properly Diagnose and Control the Disease North Carolina State University Breen, Matthew Closed Oncology
1826 1826: A Novel Treatment for Brain Tumors Using a One Medicine Approach University of Georgia Platt, Simon Open Oncology
1822 1822: Beyond the Genome: The Intersection of Genes and the Environment in Canine Cancer University of California, Los Angeles Wayne, Robert Closed Oncology
1806 1806: A Novel Virus-Based Anti-Tumor Treatment for Canine Osteosarcoma Auburn University Smith, Bruce Closed Oncology
2465 2465: Identification and Characterization of Genetic Mutations in Canine Mast Cell Tumors University of California, Davis London, Cheryl Closed Oncology
1787 1787: Clinical Advancement of a Cancer Vaccine in Dogs University of Pennsylvania Mason, Nicola Open Oncology
1759 1759: Disrupting the Differentiation of Cancer Stem Cells to Prevent the Spread of Hemangiosarcoma University of Minnesota Modiano, Jaime Closed Oncology
01726-A 01726-A: Identifying Growth Factors That Promote the Spread of Osteosarcoma Oregon State University Helfand, Stuart Closed Oncology
1093B-T 1093B-T: Positional Cloning of the Gene(s) for Gastric Cancer in the Chow Chow Tufts Medical Center McNiel, Elizabeth Closed Oncology
01708-A 01708-A: Validation of a general method for enrichment of canine cancer stem cells University of Minnesota O'Brien, Timothy Closed Oncology
01704-A 01704-A: Expression and distribution of Receptor Activator of Nuclear factor kB Ligand (RANK-L) and its receptor RANK in canine osteosarcoma Oregon State University S�guin, Bernard Closed Oncology
01703-A 01703-A: Enhancing Natural Anti-Tumor Immune Responses during Chemotherapy Auburn University Smith, Annette Closed Oncology
01698-A 01698-A: Immunohistochemical quantification of the transcobalamin II protein and receptor in naturally occurring canine tumors. Bauer Research Foundation Sysel, Annette Closed Oncology
01692-A 01692-A: Accurate Diagnosis of Mast Cell Tumor Metastasis Tufts University Donohue-Rolfe, Arthur Closed Oncology
01689-A 01689-A: Increasing the Effectiveness of Radiation Therapy in Treatment of Mast Cell Tumors Louisiana State University Shiomitsu, Keijiro Open Oncology
01686-A 01686-A: Identifying Drugs That Will Kill Cancer Stem Cells Tufts University Burgess, Kristine Closed Oncology
01683-A 01683-A: Improving Resection of Tumors through Enhanced Imaging University of Pennsylvania Holt, David Closed Oncology
01672-A 01672-A: Isolation and Characterization of Tumor Initiating Cells in Canine Osteosarcoma Cell Lines Texas A&M Research Foundation Wilson, Heather Closed Oncology
01669-A 01669-A: Determining the Role of Bacterial Infection in Complications after Chemotherapy University of Wisconsin, Madison Bach, Jonathan Open Oncology
1660 1660: Identifying the Genes That Confer Risk for Osteosarcoma The Research Institute at Nationwide Children's Hospital Alvarez, Carlos Open Oncology
1657 1657: Defining New Therapeutic Approaches for Osteosarcoma through Genome Wide Screening and Comparative Oncology St Vincent's Institute of Medical Research Walkley, Carl Closed Oncology
1651 1651: Serum Antibody Reactivity Profiling for Canine Lymphoma Detection and Monitoring Arizona State University Johnston, Stephen Closed Oncology
1633 1633: Novel Therapy for Melanoma, Lymphoma, Meningioma and Nephroblastoma Texas A&M AgriLife Research Wilson, Heather Closed Oncology
1585 1585: Evaluating a Safer, Less Toxic Radiation Therapy in the Treatment of Lymphoma Texas A&M Research Foundation Deveau, Michael Closed Oncology
1577 1577: Identifying the Genes Conferring Risk for Transitional Cell Carcinoma National Human Genome Research Institute Ostrander, Elaine Open Oncology
1569 1569: Evaluation of a Novel Drug to Treat Canine Cutaneous Lymphoma Colorado State University Thamm, Douglas Open Oncology
1557 1557: Narrowing the Search for the Genetic Basis of Histiocytic Malignancies North Carolina State University Breen, Matthew Closed Oncology
01545-A 01545-A: Pilot Study to Assess Folate Receptor Expression in Canine High-Grade Multicentric Lymphoma Purdue University Childress, Michael Closed Oncology
01542-A 01542-A: The Effects of Baicalein on Canine Osteosarcoma Cells Cornell University Wakshlag, Joseph Closed Oncology
01410B 01410B: Positional Cloning of Histiocytic Sarcoma (HS) in the Bernese Mountain Dog (BMD) and Flat Coated Retriever (Part B - See also 01410A) CNRS - University of Rennes Andre, Catherine Closed Oncology
01524-A 01524-A: Leukocyte Oxidative Burst Activity in Peripheral Blood of Dogs with Lymphoma University of Missouri, Columbia Axiak, Sandra Closed Oncology
22101 22101: Development of Anti-Canine Il-2Ra Antibodies Using CpG Oligodeoxynucleotide Vaccination University of Wisconsin, Madison Helfand, Stuart Closed Oncology
01503-A 01503-A: Rational Development of Targeted Therapy - Aurora Kinase Inhibition in Osteosarcoma University of Minnesota Modiano, Jaime Closed Oncology
01502-A 01502-A: Myxoma virus oncolytic therapy in mouse models of canine cancer University of Illinois MacNeill, Amy Closed Oncology
01494-A 01494-A: Identifying the cause of drug resistance in canine lymphoma Louisiana State University Boudreaux, Bonnie Closed Oncology
01490-A 01490-A: Evaluation of Aurora kinase inhibitors in canine lymphoma in vitro Louisiana State University Shiomitsu, Keijiro Closed Oncology
1484 1484: Identification and Characterization of a Canine Derived Single Chain Antibody that Binds and Neutralizes Canine VEGF University of Pennsylvania Mason, Nicola Closed Oncology
1472 1472: Enhanced Killing of Malignant Histiocytosis with a Novel Combination of Anti-Tumor Drugs Colorado State University Dow, Steven Closed Oncology
1429 1429: Mechanistic Relationship of IL-8 in Cell Proliferation and Survival of Canine Hemangiosarcoma University of Minnesota Modiano, Jaime Closed Oncology
1426 1426: Personalized Medicine for the Treatment of Canine Mast Cell Tumors Colorado State University Thamm, Douglas Closed Oncology
1422 1422: Targeting iNOS in Canine Oral Melanoma University of Texas Ellerhorst, Julie Closed Oncology
1418 1418: Harnessing a Dog's Own Immune System to Kill Lymphoma Tumor Cells Texas A&M Research Foundation Wilson, Heather Open Oncology
01410A 01410A: Positional Cloning of Histiocytic Sarcoma (HS) in the Bernese Mountain Dog (BMD) and Flat Coated Retriever (Part A - See also 01410B) National Human Genome Research Institute Ostrander, Elaine Closed Oncology
01384-A 01384-A: Improved Imaging to Monitor Therapy Response of Urinary Bladder Cancer Using 3D Volume Ultrasonography Purdue University Naughton, James Closed Oncology
0002254B 0002254B: Heritable and Sporadic Genetic Lesions in Canine Lymphoma and Osteosarcoma North Carolina State University Breen, Matthew Closed Oncology
01376-A 01376-A: Immunohistochemical Detection of Retinoid Receptor Alpha (RARa) in Naturally Occurring Cases of Cutaneous Mast Cell Tumors in Dogs University of Missouri, Columbia Souza, Carlos Closed Oncology
0002254A 0002254A: Heritable and Sporadic Genetic Lesions in Canine Lymphoma and Osteosarcoma AMC Cancer Research Center Modiano, Jaime Closed Oncology
01355-A 01355-A: Expression of Vascular Endothelial markers in Canine Hemangiosarcoma and their use in Diagnostic Cytology Using Immunocytochemistry University of Illinois Barger, Anne Closed Oncology
01344-A 01344-A: Comparison of percentage of T regulatory cells in dogs with spontaneously occurring lymphoma following oral versus intravenous cyclophosphamide University of Missouri, Columbia Selting, Kimberly Closed Oncology
01336B 01336B: Finding the Mutations that Increase Susceptibility to Transitional Cell Carcinoma in the Scottish Terrier, West Highland Terrier, and Shetland Sheepdog National Human Genome Research Institute Ostrander, Elaine Closed Oncology
01336A 01336A: Finding the Mutations that Increase Susceptibility to Transitional Cell Carcinoma in the Scottish Terrier, West Highland Terrier, and Shetland Sheepdog Purdue University Knapp, Deborah Closed Oncology
1317 1317: Mutation Detection and Functional Analysis of Multiple Loci for Osteosarcoma Broad Institute Lindblad-Toh, Kerstin Closed Oncology
2222 2222: Molecular Control of Prostaglandin Synthesis in Canine Mammary Tumors University of Montreal Dore, Monique Closed Oncology
01232-A 01232-A: Investigation of NF-kB as a Therapeutic Target in Canine Lymphoma University of Pennsylvania Mason, Nicola Closed Oncology
01226-A 01226-A: Evaluation of Multidrug Resistance Genes in Primary Canine Lymphoma Cells Exposed to Enrofloxacin and Prednisolone Auburn University Smith, Annette Closed Oncology
01194-A 01194-A: Role of Hypoxia-Related Factors in Dog Glioblastoma Invasion Texas A&M University Stoica, George Closed Oncology
01192-A 01192-A: Metabolism and Action of Gemcitabine in Canine Osteosarcoma Cell Lines University of California, Davis Rodriguez Jr, Carlos Closed Oncology
0002214T 0002214T: Identification of a 5-10Mb BAC Set as a Cytogenetic Resource and for the Development of an Ordered CGH Microarray for Cancer Studies in the Dog North Carolina State University Breen, Matthew Closed Oncology
01187-A 01187-A: The Role of mTOR in Canine Lymphoma University of California, Davis Kent, Michael Closed Oncology
2214 2214: Identification of a 5-10Mb BAC Set as a Cytogenetic Resource and for the Development of an Ordered CGH Microarray for Cancer Studies in the Dog Animal Health Trust Breen, Matthew Closed Oncology
01178-A 01178-A: Radiosensitization of Canine Osteosarcoma with Rapamycin University of California, Davis Kent, Michael Closed Oncology
01175-A 01175-A: Pilot Investigation of the Causes of Hemangiosarcoma in Clumber Spaniels Van Andel Research Institute Duesbery, Nicholas Closed Oncology
01169-A 01169-A: Identifying Mutations in Genes Associated with Canine Hemangiosarcoma: Denser Fine Mapping of the Associated Locus in Chromosome 26 Tufts University Azuma, Chieko Closed Oncology
01168-A 01168-A: Identifying Mutations in Genes Associated with Canine Hemangiosarcoma: Denser Fine Mapping of the Associated Locus in Chromosome 5 Tufts University Azuma, Chieko Closed Oncology
1152 1152: Liposomal BisphosphonateTherapy for Malignant Histiocytosis Colorado State University Dow, Steven Closed Oncology
1147 1147: Identifying Mutations in Genes Associated with Canine Hemangiosarcoma Tufts University Azuma, Chieko Closed Oncology
1139 1139: Immune Targeting of Canine Hemangiosarcoma Using a Canine Derived Single Chain Antibody Approach University of Pennsylvania Mason, Nicola Closed Oncology
1131 1131: Genetic Background and the Angiogenic Phenotype in Cancer University of Minnesota Modiano, Jaime Closed Oncology
1130 1130: Measurement of Minimal Residual Disease Using Real Time PCR in Canine Lymphoma Colorado State University Lana, Susan Closed Oncology
2105 2105: Characterization of Host and Environmental Risk Factors for Urinary Bladder Cancer in a High Risk Breed (the Scottish Terrier) Purdue University Knapp, Deborah Closed Oncology
1113 1113: Canine Non-Hodgkin Lymphoma: Characterization and Prognostic Value of Cancer Stem Cells University of Minnesota O'Brien, Timothy Closed Oncology
01093B 01093B: Positional Cloning of the Gene(s) for Gastric Cancer in the Chow Chow Michigan State University McNiel, Elizabeth Closed Oncology
01093A 01093A: Positional Cloning of the Gene(s) for Gastric Cancer in the Chow Chow National Human Genome Research Institute Ostrander, Elaine Closed Oncology
01064-A 01064-A: Immunocytochemical Detection and siRNA-Mediated Knockdown of Survivin in Canine Lymphoma Colorado State University Thamm, Douglas Closed Oncology
01054-A 01054-A: Adult NeurogenesisA Source of Dog Glioblastoma Multiforme (GBMs) Brain Tumor Development Texas A&M University Stoica, George Closed Oncology
01052-A 01052-A: Whole Genome Association Mapping of Squamous Cell Carcinoma (SCC) of the Digit in the Standard Poodle National Human Genome Research Institute Ostrander, Elaine Closed Oncology
0002038T 0002038T: The Molecular Cytogenetics of Canine Lymphosarcoma: Correlating Chromosomal Changes with Clinical Disease North Carolina State University Breen, Matthew Closed Oncology
00830-AT 00830-AT: A Pilot Study to Determine the Molecular Characterization of Canine Follicular Thyroid Carcinoma University of Minnesota Wilke, Vicki Closed Oncology
01046-A 01046-A: The Relevance of Ezrin in the Metastatic Progression of Canine Osteosarcoma National Cancer Institute Hong, Sung Closed Oncology
2038 2038: The Molecular Cytogenetics of Canine Lymphosarcoma: Correlating Chromosomal Changes with Clinical Disease Texas A&M University Dunstan, Robert Closed Oncology
00615A-T 00615A-T: Heritable and Sporadic Genetic Lesions in Canine Lymphoma University of Minnesota Modiano, Jaime Closed Oncology
01029-A 01029-A: Preliminary Pharmacokinetics and Palatability Study of Freeze-Dried Black Raspberries in Healthy Dogs Ohio State University Lord, Linda Closed Oncology
2035 2035: Transferrin Receptor Expression by Canine Brain Tumors North Carolina State University Olby, Natasha Closed Oncology

Help Future Generations of Dogs

Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.

Learn How to Help

Make an Investment Today:

  • $40
  • $60
  • $100
  • $250
  • Give Now
Connect With Us:
Get Canine Health News:
Please leave this field empty
Canine Health
Educational Resources
Research
American Kennel Club Canine Health Foundation, Inc

P.O. Box 900061, Raleigh, NC 27675
(888)-682-9696

  

© 2016 AKC Canine Health Foundation | Privacy Policy | Site Map

Site by Blackbaud, Inc.

Powered by Blackbaud
nonprofit software